Artificial intelligence (AI) is becoming increasingly important in pharmaceutical manufacturing, laboratory operations, clinical research, and other regulated industries. Organizations use AI-based computerized systems to analyze data, support quality decisions, identify risks, and improve operational efficiency. However, when these systems support regulated activities, they must meet applicable Good Practice (GxP) requirements.

Validating AI-based computerized systems in a GxP environment requires a structured approach that goes beyond traditional Computerized System Validation (CSV). Unlike conventional software, some AI systems can produce results that depend on training data, model configuration, changing inputs, or model updates. Therefore, organizations must understand how these systems work, what risks they introduce, and how their performance can be monitored throughout their lifecycle.

This guide explains how to validate AI-based computerized systems in a GxP environment, covering intended use, training data, model development, human oversight, data integrity, and ongoing monitoring.

GxP Cellators provides GxP auditing, computerized system validation support, data integrity assessments, and regulatory compliance services to help organizations evaluate AI-related compliance risks and strengthen their validation processes.

What Is AI-Based Computerized System Validation in GxP?

AI-based computerized system validation is the documented process of establishing that an AI-enabled system is suitable for its intended use and performs reliably within its defined operating environment. The validation approach should be proportionate to the system’s intended use, complexity, and potential impact on product quality, patient safety, and data integrity.

Traditional CSV principles remain relevant, including documented requirements, risk assessment, testing, traceability, change control, and periodic review. However, AI systems may require additional controls because their outputs can be influenced by training data, model behavior, and changes in the operating environment.

For example, an AI tool used to support laboratory result review may affect decisions about data quality. Similarly, an AI application used in pharmaceutical manufacturing may help identify process deviations. If such systems support GxP activities, organizations should establish appropriate controls and document how their reliability and suitability have been evaluated.

AI validation does not automatically require the same testing approach for every system. Instead, the validation strategy should reflect the actual risks and intended use.

Step 1: Define Intended Use and Requirements

The first step is to clearly define the intended use of the AI-based computerized system. Organizations should document what the system is designed to do, which processes it supports, and how its outputs will be used.

A clear intended-use statement helps determine the scope of validation and the controls required throughout the system lifecycle.

Key activities include:

• Documenting the intended use and purpose of the AI system.
• Defining functional and non-functional requirements.
• Identifying the GxP activities supported by the system.
• Assessing potential impacts on product quality, patient safety, and data integrity.
• Establishing measurable acceptance criteria.
• Identifying system users, responsibilities, and access requirements.

A risk assessment should also determine the potential consequences of incorrect, incomplete, or unreliable AI outputs. For example, an AI system that provides recommendations for a quality decision may require different controls from one that performs a purely administrative task.

Requirements should be clear enough to support objective testing. Where an AI model produces probabilistic outputs, acceptance criteria should explain how its performance will be assessed and what limitations apply.

Step 2: Assess and Prepare Training Data

Training data plays a major role in AI system performance. Incomplete, inaccurate, unrepresentative, or biased data can affect model outputs and introduce compliance risks.

Therefore, organizations should evaluate the quality and suitability of training, validation, and test datasets as applicable to the AI model and its intended use.

Important activities include:

• Documenting training data sources and ownership.
• Assessing data completeness, accuracy, and representativeness.
• Recording data cleaning and preprocessing activities.
• Evaluating potential bias in the datasets.
• Establishing controls for data access and protection.
• Documenting known data limitations and their potential impact.
• Maintaining traceability between datasets, model versions, and validation evidence.

Data preparation activities should be documented so that reviewers can understand how the data was selected, transformed, and used.

Organizations should also determine whether the data reflects the conditions in which the AI system will operate. A model trained using one type of process or dataset may not perform equally well under different conditions.

For GxP applications, training data quality assessments should be proportionate to the risk. Where data supports critical decisions, stronger evidence of data suitability, traceability, and integrity may be necessary.

Step 3: Document Model Development and Validation

AI model development should be sufficiently documented to support review, testing, and future maintenance. The level of detail will depend on the model type, system architecture, intended use, and regulatory risk.

Organizations should maintain records that explain how the model was developed and how its performance was evaluated.

Documentation should cover:

• Model development methodology and architecture.
• Key assumptions and known limitations.
• Training, validation, and test data used.
• Model configuration and version information.
• Testing methods and performance metrics.
• Validation results and acceptance criteria.
• Identified risks and mitigation measures.
• Approval records and supporting evidence.

Testing should evaluate whether the model performs as expected under defined conditions. Depending on the intended use, this may include accuracy, precision, sensitivity, specificity, robustness, reproducibility, or other appropriate performance measures.

Organizations should also consider how the model behaves with unusual, incomplete, or unexpected inputs. Testing only typical scenarios may not provide sufficient evidence of suitability for a regulated application.

Where applicable, the validation package should establish traceability between requirements, identified risks, test cases, results, and conclusions. This makes it easier to demonstrate why the system is considered suitable for its intended use.

Step 4: Establish Appropriate Human Oversight

Human oversight is an important control when AI outputs influence GxP decisions. Organizations should clearly define when human review is required, who is responsible for reviewing outputs, and what actions can be taken when the system produces questionable results.

Human oversight should be based on risk rather than treated as a general approval step.

Key activities include:

• Defining human review and approval procedures.
• Establishing override, rejection, and escalation processes.
• Documenting significant human interventions.
• Training personnel on the system’s capabilities and limitations.
• Defining responsibilities for investigating unexpected outputs.
• Maintaining records of decisions where required.

For example, if an AI system flags a potential quality issue, a qualified person may need to review the supporting evidence before taking further action. The review process should explain how disagreements between the AI output and human judgment are handled.

Training should help users understand that AI outputs may contain errors and should not automatically be accepted as correct. Personnel must also know when to escalate concerns and how to report unexpected system behavior.

The required level of oversight will depend on the system’s intended use, risk classification, and role in regulated decision-making.

Step 5: Implement Data Integrity and Security Controls

Data integrity is essential when AI-based computerized systems process or generate information used in GxP activities. Organizations should establish appropriate controls to protect records from unauthorized access, unintended changes, loss, or inappropriate deletion.

The controls should support applicable data integrity principles and relevant regulatory requirements.

Important measures include:

• Implementing role-based access controls.
• Maintaining appropriate audit trails for relevant records and activities.
• Recording model versions and significant configuration changes.
• Protecting input data, outputs, and associated metadata.
• Establishing backup and recovery procedures.
• Documenting data transfers and system interfaces.
• Reviewing security risks and access permissions periodically.
• Monitoring relevant data integrity issues.

Audit trails should provide suitable evidence of important activities, such as changes to records, model configurations, and system settings, where applicable. Organizations should also determine whether AI-generated outputs need to be retained and linked to the information used to produce them.

Data governance procedures should define responsibilities for managing datasets, model updates, access permissions, and records retention. These controls help maintain traceability and support investigations when unexpected results occur.

Step 6: Establish Ongoing Monitoring and Periodic Review

AI validation should not end when a system is initially approved. Depending on the technology, intended use, and risk, ongoing monitoring may be necessary to confirm that the system continues to perform as expected.

Changes in data, operating conditions, software components, or model versions can affect performance. Organizations should therefore establish a documented process for reviewing system performance throughout its lifecycle.

Ongoing monitoring activities may include:

• Defining relevant performance indicators.
• Establishing monitoring thresholds and review responsibilities.
• Monitoring unexpected outputs and performance degradation.
• Recording incidents, deviations, and investigations.
• Evaluating proposed model or configuration changes.
• Scheduling risk-based periodic reviews.
• Updating validation documentation when necessary.
• Establishing response and escalation plans.

Organizations should define what happens when a system fails to meet its established acceptance criteria. Depending on the impact, possible actions may include additional investigation, restricting system use, reverting to an approved configuration, or performing further testing before reapproval.

A formal change control process should determine whether changes require additional testing, regression testing, or partial or full revalidation. The decision should be documented and based on risk.

Common Challenges in AI-Based GxP Validation

Organizations may encounter several challenges when validating AI-enabled systems. Understanding these issues early can help establish a more effective validation strategy.

Limited Model Transparency

Some AI models are difficult to interpret. Organizations should document the available information about model behavior, limitations, and suitability for the intended use.

Inadequate Training Data

Poor-quality or unrepresentative datasets may lead to unreliable outputs. Data quality assessments and documented data governance procedures can help reduce this risk.

Changing Model Performance

AI systems may perform differently when operating conditions or input data change. Risk-based monitoring and defined escalation procedures help identify potential problems.

Insufficient Documentation

Missing records can make it difficult to demonstrate that the system has been adequately assessed. Requirements, testing evidence, model versions, approvals, and change records should be maintained appropriately.

Unclear Human Responsibilities

Without defined responsibilities, users may rely too heavily on AI-generated outputs. Organizations should document review requirements, decision authority, and escalation procedures.

Addressing these challenges during planning can help organizations build a stronger validation lifecycle and improve inspection readiness.

How GxP Cellators Supports AI-Based CSV Validation

GxP Cellators provides GxP auditing and compliance support to help pharmaceutical and other regulated organizations assess computerized systems and related quality processes.

Its support can help organizations identify documentation gaps, evaluate data integrity controls, review validation evidence, and assess whether established procedures address relevant compliance risks.

AI CSV Validation and Auditing Support

Services may include:

• Validation strategy and documentation reviews.
• AI model validation audits.
• Training data quality assessments.
• Data integrity audits.
• Human oversight process reviews.
• Regulatory compliance assessments.
• Mock inspection support.
• CAPA review and follow-up verification.
• Risk assessment and gap identification.

Why Choose GxP Cellators?

GxP Cellators focuses on practical, risk-based compliance support for regulated environments.

Organizations can benefit from:

• Experience across computerized system validation and GxP compliance.
• Reviews informed by applicable FDA, EMA, Health Canada, MHRA, and WHO requirements and guidance.
• Risk-based assessments tailored to the intended use of the system.
• Actionable findings and recommendations.
• Confidential handling of proprietary business and system information.

The precise validation requirements depend on the system, intended use, applicable regulations, and organizational quality procedures. GxP Cellators can help organizations assess their current approach and identify areas that may require improvement.

Best Practices for AI-Based Computerized System Validation

To strengthen the validation process, organizations should follow a structured and documented approach.

1. Start with intended use: Define the purpose and GxP impact before selecting validation activities.
2. Apply risk-based controls: Focus testing and oversight on risks to product quality, patient safety, and data integrity.
3. Maintain traceability: Link requirements, risks, test results, approvals, and relevant model versions.
4. Evaluate data quality: Document data sources, preparation methods, limitations, and suitability.
5. Define human responsibilities: Establish clear review, approval, override, and escalation procedures.
6. Control changes: Assess the impact of software, configuration, data, and model changes.
7. Monitor performance: Establish appropriate monitoring and periodic review procedures.
8. Prepare for inspection: Keep validation records organized, accessible, and consistent with approved procedures.

Following these practices can help organizations manage AI-related risks while maintaining an appropriate level of control over regulated computerized systems.

Frequently Asked Questions

Q1. What is the first step in validating an AI-based computerized system?

The first step is defining the intended use and requirements. Organizations should document what the AI system is designed to do, which GxP activities it supports, and the potential risks associated with its outputs.

Q2. How is training data validated for GxP AI systems?

Training data is assessed by documenting its sources, evaluating completeness and representativeness, reviewing preprocessing activities, and identifying potential bias. The assessment should also consider data integrity, traceability, and suitability for the intended use.

Q3. What human oversight is required for AI systems in GxP?

Human oversight may include defined review and approval procedures, override and rejection processes, escalation requirements, and documented interventions. The level of oversight should reflect the system’s intended use and risk.

Q4. How does AI-based CSV differ from traditional CSV?

Traditional CSV focuses on demonstrating that a computerized system meets its requirements and performs as intended. AI-based CSV retains these principles but may require additional assessment of training data, model performance, limitations, changing inputs, and ongoing monitoring.

Q5. Does an AI-based computerized system require revalidation after every update?

Not necessarily. Organizations should evaluate each proposed change through a documented change control and risk assessment process. Additional testing or revalidation should be determined by the potential impact of the change on the system’s validated state.

Q6. How does GxP Cellators support AI-based CSV validation?

GxP Cellators offers support such as validation documentation reviews, AI model validation audits, training data quality assessments, data integrity audits, regulatory compliance reviews, mock inspections, and CAPA follow-up verification.

Q7. Which regulatory requirements apply to AI-based GxP systems?

Requirements depend on the system’s intended use, industry, and applicable jurisdiction. Organizations should evaluate relevant regulatory requirements and guidance, including applicable FDA and EMA expectations, computerized system validation principles, and data integrity requirements.

Q8. How can I contact GxP Cellators for AI-based CSV validation support?

Visit the GxP Cellators contact page at https://www.gxpcellators.com/contact/ to discuss your computerized system validation, AI auditing, data integrity, or GxP compliance requirements.

Conclusion

Validating AI-based computerized systems in a GxP environment requires a documented, risk-based approach that considers intended use, data quality, model performance, human oversight, data integrity, and ongoing monitoring. Organizations should establish clear requirements, maintain appropriate validation evidence, and evaluate changes throughout the system lifecycle.

As AI adoption increases across regulated industries, effective validation and governance become increasingly important. A well-designed validation process can help organizations identify potential risks, improve system reliability, and support regulatory compliance.

GxP Cellators provides GxP auditing and compliance support to help organizations evaluate their validation practices and identify opportunities for improvement.

Contact GxP Cellators: https://www.gxpcellators.com/contact/